Buchumschlag

Correction to “RTP801 is a critical factor in the neurodegeneration process of A53T a‐synuclein in a mouse model of Parkinson's disease under chronic restraint stress”

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	British Journal of Pharmacology
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Vesicular glutamate transporter VGLUT2 expression emerges in substantia nigra dopamine neurons in mouse models of parkinsonism in the absence of neurodegeneration
von: Sivakumar Srinivasan, et al.
Veröffentlicht: (2025)

Role for the liver X receptor agonist 22‐ketositosterol in preventing disease progression in an Alzheimer's disease mouse model
von: Nikita Martens, et al.
Veröffentlicht: (2025)

QM107, a novel CD148 (RTP Type J) activating peptide therapy for treating neovascular age‐related macular degeneration
von: Samantha Arokiasamy, et al.
Veröffentlicht: (2024)

Advancing Alzheimer's disease pharmacotherapy: efficacy of glucocorticoid modulation with dazucorilant (CORT113176) in preclinical mouse models
von: Geoffrey Canet, et al.
Veröffentlicht: (2025)

Matsupexole: A novel nonergot dopamine receptor agonist with sustained efficacy in a rat model of Parkinson's disease and limited off‐target activity
von: Takayuki Suzuki, et al.
Veröffentlicht: (2026)

A p75 neurotrophin receptor‐sparing nerve growth factor protects retinal ganglion cells from neurodegeneration by targeting microglia
von: Laura Latini, et al.
Veröffentlicht: (2024)

A pH‐sensitive opioid does not exhibit analgesic tolerance in a mouse model of colonic inflammation
von: Claudius E. Degro, et al.
Veröffentlicht: (2024)

Population modelling of nilotinib exposure vs . longitudinal BCR::ABL1 response in patients with chronic phase chronic myeloid leukaemia using a semimechanistic disease model
von: Sherwin K. B. Sy, et al.
Veröffentlicht: (2024)

Decreased extrasynaptic δ‐GABAA receptors in PNN‐associated parvalbumin interneurons correlates with anxiety in APP and tau mouse models of Alzheimer's disease
von: Weicong Zhang, et al.
Veröffentlicht: (2024)

Innovative pharmacotherapy for hepatic metabolic and chronic inflammatory diseases in China
von: Feng Zhang, et al.
Veröffentlicht: (2024)

GNS561 (ezurpimtrostat), a small basic lipophilic molecule, prevents lupus phenotype in a pristane‐induced lupus mouse model
von: Eya Toumi, et al.
Veröffentlicht: (2025)

Clemastine attenuates subarachnoid haemorrhage pathology in a mouse model via Nrf2/SQSTM1‐mediated autophagy
von: Yan Zou, et al.
Veröffentlicht: (2025)

Plumbagin, a novel TRPV2 inhibitor, ameliorates microglia activation and brain injury in a middle cerebral artery occlusion/reperfusion mouse model
von: Meihuizi Ding, et al.
Veröffentlicht: (2024)

Psilocybin as a novel treatment for chronic pain
von: Tate Askey, et al.
Veröffentlicht: (2024)

Pharmacokinetics and cardioprotective efficacy of intravenous miR‐125b* microRNA mimic in a mouse model of acute myocardial infarction
von: Tamara Szabados, et al.
Veröffentlicht: (2024)

TRPA1 up‐regulation mediates oxidative stress in a pulpitis model in vitro
von: Árpád Kunka, et al.
Veröffentlicht: (2024)

Blockade of cannabinoid CB1 receptors potentiates the anti‐fibrotic effects mediated by SGLT2 inhibition in a mouse model of diabetic nephropathy
von: Océane Pointeau, et al.
Veröffentlicht: (2025)

Deacetylation of BAP31 by sirtuin 2 attenuates apoptosis of hepatocytes induced by endoplasmic reticulum stress, in chronic alcoholic liver injury
von: Sai Wang, et al.
Veröffentlicht: (2025)

Inhibition of GRK2 mitigates cisplatin‐induced acute and chronic nephrotoxicity by targeting the NADPH oxidase 4/oxidative stress axis
von: Fei Duan, et al.
Veröffentlicht: (2026)

Increased ATP production and P‐glycoprotein activity underlie the marked changes in blood–brain barrier transport of drugs in a mouse model of amyotrophic lateral sclerosis
von: Yijun Pan, et al.
Veröffentlicht: (2025)

Population pharmacokinetic/target engagement modelling of tozorakimab in healthy volunteers and patients with chronic obstructive pulmonary disease
von: Muhammad Waqas Sadiq, et al.
Veröffentlicht: (2024)

TREM2 activation suppresses central sensitisation by promoting autophagy in a chronic migraine model with recurrent nitroglycerin stimulation in mice
von: Suifa Hu, et al.
Veröffentlicht: (2026)

Elucidating the beneficial impact of exercise on chronic obstructive pulmonary disease and its comorbidities: Integrating proteomic and immunological insights
von: Xishuai Wang, et al.
Veröffentlicht: (2024)

Trained immunity: A link between risk factors and cardiovascular disease
von: Mingqi Chen, et al.
Veröffentlicht: (2024)

First‐in‐human assessment of safety and pharmacokinetics of EP9001A:an anti‐nerve growth factor antibody for chronic pain treatment
von: Yue Cheng, et al.
Veröffentlicht: (2025)

Systemic EP4 receptor agonist and Arginase‐1 therapy in a murine model of chronic asthma and influenza virus‐induced asthma exacerbation
von: Tim Lange, et al.
Veröffentlicht: (2025)

Biphasic effect of nicotine on glutamatergic activity in male mouse brain
von: Prajakta Pramod Biyani, et al.
Veröffentlicht: (2025)

Pharmacokinetic‐pharmacodynamic (PK/PD) modelling of cotadutide effect in patients with chronic kidney disease and type 2 diabetes mellitus
von: Hongtao Yu, et al.
Veröffentlicht: (2025)

FM‐dye inhibition of Piezo2 relieves mechanically evoked pain in mouse models of acute inflammatory and osteoarthritic knee pain
von: Natalie S. Adamczyk, et al.
Veröffentlicht: (2026)

Daidzein ameliorates nonmotor symptoms of manganese‐induced Parkinsonism in zebrafish model: Behavioural and biochemical approach
von: Balasubramanian Haridevamuthu, et al.
Veröffentlicht: (2024)

Medication review interventions for adults living with advanced chronic kidney disease: A scoping review
von: Cathy Margaret Pogson, et al.
Veröffentlicht: (2024)

Renoprotective effects of dapagliflozin in diabetic patients with chronic kidney disease: A retrospective observational study
von: Sara Al Lawati, et al.
Veröffentlicht: (2026)

The persistence of chronic opioid use in patients with inflammatory bowel disease—A nationwide cohort study
von: Bente Mertz Nørgård, et al.
Veröffentlicht: (2025)

A systematic review of medication adherence and mortality in chronic disease: Implications for clinical guidelines and policy
von: Jessica Hamuy Blanco, et al.
Veröffentlicht: (2025)

Psychotropic medication use among community dwellers with and without Parkinson's disease – A nationwide cohort study
von: Noora Nieminen, et al.
Veröffentlicht: (2026)

Bruton tyrosine kinase (Btk) in neutrophils is indispensable for initiating and maintaining skin inflammation in a model of pemphigoid diseases
von: Henning Olbrich, et al.
Veröffentlicht: (2026)

Comment on ‘Renoprotective effects of dapagliflozin in diabetic patients with chronic kidney disease: A retrospective observational study’
von: Jia Chen, et al.
Veröffentlicht: (2026)

Identification of active ingredients from Lamiophlomis rotata that increase wound repair in mouse skin
von: Huan Li, et al.
Veröffentlicht: (2025)

Improving cefazolin exposure in critically ill children using a population pharmacokinetic model
von: Clémence Rivaud, et al.
Veröffentlicht: (2024)

Correction to ‘Sphingosine‐1‐phosphate/TGF‐β axis drives epithelial mesenchymal transition in asthma‐like disease’
Veröffentlicht: (2024)